Project |
|
|
|
Titel van het project : Translational research in the randomized phase III EORTC 55041 study of Erlotinib versus observation in patients with no evidence of disease progression after first line, treatment for ovarian epithelial cancer
Toegkend bedrag : € 100 000, verdeeld over 3 jaar |













